Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma
Following neoadjuvant therapy, post-treatment MRI frequently underestimates tumor size in ILC, particularly in tumors with NME. Surgeons should consider these imaging limitations when planning resection, which could improve surgical outcomes.
Authors
- Tesia McKenzie
- Amie Y. Lee (ORCID: https://orcid.org/0000-0001-7682-5023)
- Mary Kathryn Abel (ORCID: https://orcid.org/0000-0003-0447-5823)
- Mandeep Kaur (ORCID: https://orcid.org/0000-0002-5544-5918)
- Maggie Chung (ORCID: https://orcid.org/0000-0002-8144-381X)
- Rita A. Mukhtar (ORCID: https://orcid.org/0000-0001-8079-7846)
- Alisha Othieno (ORCID: https://orcid.org/0000-0002-3481-8359)
- Astrid Quirarte (ORCID: https://orcid.org/0009-0003-9321-4808)
- Anna Vertido
Institutions
- Harvard University (US)
- University of California, San Francisco (US)
- University of California System (US)
- Kaiser Permanente Roseville Medical Center (US)
- Hackensack Meridian Health (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1245/s10434-025-17735-6
- Citations
- 2
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 2.72